pharmaceutical companies

Big Pharma Battles Doctors Over Costly Drug for Infants

Big Pharma Battles Doctors Over Costly Drug for Infants
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine. The dispute involves new guidelines from the American Academy of Pediatrics, which say medical evidence shows the drug benefits few children other than very young preemies.
origin Author: 
Lindsey Tanner
origin Blog: